A novel molecular signature identified by systems genetics approach predicts prognosis in oral squamous cell carcinoma

Chien Hua Peng, Chun Ta Liao, Shih Chi Peng, Yin Ju Chen, Ann Joy Cheng, Jyh Lyh Juang, Chi Ying Tsai, Tse Ching Chen, Yung Jen Chuang, Chuan Yi Tang, Wen Ping Hsieh, Tzu Chen Yen

Research output: Contribution to journalArticle

91 Citations (Scopus)

Abstract

Molecular methods for predicting prognosis in patients with oral cavity squamous cell carcinoma (OSCC) are urgently needed, considering its high recurrence rate and tendency for metastasis. The present study investigated the genetic basis of variations in gene expression associated with poor prognosis in OSCC using Affymetrix SNP 6.0 and Affymetrix GeneChip Human Gene 1.0 ST arrays. We identified recurrent DNA amplifications scattered from 8q22.2 to 8q24.3 in 112 OSCC specimens. These amplicons demonstrated significant associations with increased incidence of extracapsular spread, development of second primary malignancies, and poor survival. Fluorescence in situ hybridization, in a validation panel consisting of 295 cases, confirmed these associations. Assessment of the effects of copy number variations (CNVs) on genome-wide variations in gene expression identified a total of 85 CNV-associated transcripts enriched in the MYC-centered regulatory network. Twenty-four transcripts associated with increased risk of second primary malignancies, tumor relapse, and poor survival. Besides MYC itself, a novel dysregulated MYC module plays a key role in OSCC carcinogenesis. This study identified a candidate molecular signature associated with poor prognosis in OSCC patients, which may ultimately facilitate patient-tailored selection of therapeutic strategies.

Original languageEnglish
Article numbere23452
JournalPLoS One
Volume6
Issue number8
DOIs
Publication statusPublished - 2011
Externally publishedYes

Fingerprint

squamous cell carcinoma
prognosis
Mouth
Squamous Cell Carcinoma
mouth
Second Primary Neoplasms
Gene expression
Genes
Gene Expression
Recurrence
gene expression
Survival
relapse
fluorescence in situ hybridization
Fluorescence In Situ Hybridization
metastasis
carcinogenesis
Patient Selection
Single Nucleotide Polymorphism
Amplification

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

A novel molecular signature identified by systems genetics approach predicts prognosis in oral squamous cell carcinoma. / Peng, Chien Hua; Liao, Chun Ta; Peng, Shih Chi; Chen, Yin Ju; Cheng, Ann Joy; Juang, Jyh Lyh; Tsai, Chi Ying; Chen, Tse Ching; Chuang, Yung Jen; Tang, Chuan Yi; Hsieh, Wen Ping; Yen, Tzu Chen.

In: PLoS One, Vol. 6, No. 8, e23452, 2011.

Research output: Contribution to journalArticle

Peng, CH, Liao, CT, Peng, SC, Chen, YJ, Cheng, AJ, Juang, JL, Tsai, CY, Chen, TC, Chuang, YJ, Tang, CY, Hsieh, WP & Yen, TC 2011, 'A novel molecular signature identified by systems genetics approach predicts prognosis in oral squamous cell carcinoma', PLoS One, vol. 6, no. 8, e23452. https://doi.org/10.1371/journal.pone.0023452
Peng, Chien Hua ; Liao, Chun Ta ; Peng, Shih Chi ; Chen, Yin Ju ; Cheng, Ann Joy ; Juang, Jyh Lyh ; Tsai, Chi Ying ; Chen, Tse Ching ; Chuang, Yung Jen ; Tang, Chuan Yi ; Hsieh, Wen Ping ; Yen, Tzu Chen. / A novel molecular signature identified by systems genetics approach predicts prognosis in oral squamous cell carcinoma. In: PLoS One. 2011 ; Vol. 6, No. 8.
@article{5cb1915271014348b330d6a39ceccbdc,
title = "A novel molecular signature identified by systems genetics approach predicts prognosis in oral squamous cell carcinoma",
abstract = "Molecular methods for predicting prognosis in patients with oral cavity squamous cell carcinoma (OSCC) are urgently needed, considering its high recurrence rate and tendency for metastasis. The present study investigated the genetic basis of variations in gene expression associated with poor prognosis in OSCC using Affymetrix SNP 6.0 and Affymetrix GeneChip Human Gene 1.0 ST arrays. We identified recurrent DNA amplifications scattered from 8q22.2 to 8q24.3 in 112 OSCC specimens. These amplicons demonstrated significant associations with increased incidence of extracapsular spread, development of second primary malignancies, and poor survival. Fluorescence in situ hybridization, in a validation panel consisting of 295 cases, confirmed these associations. Assessment of the effects of copy number variations (CNVs) on genome-wide variations in gene expression identified a total of 85 CNV-associated transcripts enriched in the MYC-centered regulatory network. Twenty-four transcripts associated with increased risk of second primary malignancies, tumor relapse, and poor survival. Besides MYC itself, a novel dysregulated MYC module plays a key role in OSCC carcinogenesis. This study identified a candidate molecular signature associated with poor prognosis in OSCC patients, which may ultimately facilitate patient-tailored selection of therapeutic strategies.",
author = "Peng, {Chien Hua} and Liao, {Chun Ta} and Peng, {Shih Chi} and Chen, {Yin Ju} and Cheng, {Ann Joy} and Juang, {Jyh Lyh} and Tsai, {Chi Ying} and Chen, {Tse Ching} and Chuang, {Yung Jen} and Tang, {Chuan Yi} and Hsieh, {Wen Ping} and Yen, {Tzu Chen}",
year = "2011",
doi = "10.1371/journal.pone.0023452",
language = "English",
volume = "6",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "8",

}

TY - JOUR

T1 - A novel molecular signature identified by systems genetics approach predicts prognosis in oral squamous cell carcinoma

AU - Peng, Chien Hua

AU - Liao, Chun Ta

AU - Peng, Shih Chi

AU - Chen, Yin Ju

AU - Cheng, Ann Joy

AU - Juang, Jyh Lyh

AU - Tsai, Chi Ying

AU - Chen, Tse Ching

AU - Chuang, Yung Jen

AU - Tang, Chuan Yi

AU - Hsieh, Wen Ping

AU - Yen, Tzu Chen

PY - 2011

Y1 - 2011

N2 - Molecular methods for predicting prognosis in patients with oral cavity squamous cell carcinoma (OSCC) are urgently needed, considering its high recurrence rate and tendency for metastasis. The present study investigated the genetic basis of variations in gene expression associated with poor prognosis in OSCC using Affymetrix SNP 6.0 and Affymetrix GeneChip Human Gene 1.0 ST arrays. We identified recurrent DNA amplifications scattered from 8q22.2 to 8q24.3 in 112 OSCC specimens. These amplicons demonstrated significant associations with increased incidence of extracapsular spread, development of second primary malignancies, and poor survival. Fluorescence in situ hybridization, in a validation panel consisting of 295 cases, confirmed these associations. Assessment of the effects of copy number variations (CNVs) on genome-wide variations in gene expression identified a total of 85 CNV-associated transcripts enriched in the MYC-centered regulatory network. Twenty-four transcripts associated with increased risk of second primary malignancies, tumor relapse, and poor survival. Besides MYC itself, a novel dysregulated MYC module plays a key role in OSCC carcinogenesis. This study identified a candidate molecular signature associated with poor prognosis in OSCC patients, which may ultimately facilitate patient-tailored selection of therapeutic strategies.

AB - Molecular methods for predicting prognosis in patients with oral cavity squamous cell carcinoma (OSCC) are urgently needed, considering its high recurrence rate and tendency for metastasis. The present study investigated the genetic basis of variations in gene expression associated with poor prognosis in OSCC using Affymetrix SNP 6.0 and Affymetrix GeneChip Human Gene 1.0 ST arrays. We identified recurrent DNA amplifications scattered from 8q22.2 to 8q24.3 in 112 OSCC specimens. These amplicons demonstrated significant associations with increased incidence of extracapsular spread, development of second primary malignancies, and poor survival. Fluorescence in situ hybridization, in a validation panel consisting of 295 cases, confirmed these associations. Assessment of the effects of copy number variations (CNVs) on genome-wide variations in gene expression identified a total of 85 CNV-associated transcripts enriched in the MYC-centered regulatory network. Twenty-four transcripts associated with increased risk of second primary malignancies, tumor relapse, and poor survival. Besides MYC itself, a novel dysregulated MYC module plays a key role in OSCC carcinogenesis. This study identified a candidate molecular signature associated with poor prognosis in OSCC patients, which may ultimately facilitate patient-tailored selection of therapeutic strategies.

UR - http://www.scopus.com/inward/record.url?scp=80051635974&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80051635974&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0023452

DO - 10.1371/journal.pone.0023452

M3 - Article

C2 - 21853135

AN - SCOPUS:80051635974

VL - 6

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 8

M1 - e23452

ER -